- Group sales increase by 28.1% to 402.0 million CHF
- EBITDA margin rises from 27.8% to 30.5% / EBIT margin rises from 19.9% to 24.0%
- Operating profit (EBIT) increases by 55.0% to 96.7 million CHF
- Creation of 272 new jobs, 201 of them in Switzerland
- Despite the challenges posed by the COVID 19 pandemic, the supply of active ingredients was secured and increased in critical areas
- Board of Directors proposes dividend increase to 3.25 CHF per share
